Literature DB >> 2500229

[Pro-cathepsin D can activate in vitro pro-cathepsin B secreted by ovarian cancers].

M Pagano1, F Capony, H Rochefort.   

Abstract

A precursor form of cathepsin B (Mr 45-47 kd) was purified from ascitic fluids of patients with ovarian adenocarcinomas. Following pepsin activation, this precursor produced a 33 kd cathepsin B-like proteinase closely related to lysosomal cathepsin B. A similar activation was found using the 52 kd pro-cathepsin D secreted by the MCF7 human breast cancer cells. This activation was a time, dose and pH dependent process. These results suggest that the 52 kd pro-cathepsin D may be involved in the early steps of the "metastatic cascade", activating pro-cathepsin B in an acidic environment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500229

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  5 in total

1.  Expression of cysteine protease inhibitors in human gliomas and meningiomas.

Authors:  M Sivaparvathi; I McCutcheon; R Sawaya; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

Review 2.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.

Authors:  B F Sloane; K Moin; E Krepela; J Rozhin
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

Review 3.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

4.  Immunocytochemical localization of cathepsin D in the rat osteoclast.

Authors:  T Goto; T Tsukuba; N Ayasaka; K Yamamoto; T Tanaka
Journal:  Histochemistry       Date:  1992

Review 5.  Cathepsin D: a protease involved in breast cancer metastasis.

Authors:  H Rochefort; F Capony; M Garcia
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.